AG
Agen Genomics, Inc.
SEC filingBiotechnology · Escondido, CA
Amount raised$25Ksold at filing
Total offering$1.5M$1.5M still open
Investors in the raise0count reported to the SEC
FiledSep 2, 2026first sale Aug 28, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christopher Scott LippeExecutive Officer
Executive officers, directors and promoters as listed on the Form D.